UnitedHealth Group Incorporated $UNH Shares Sold by Coppell Advisory Solutions LLC

Coppell Advisory Solutions LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 65.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,686 shares of the healthcare conglomerate’s stock after selling 3,247 shares during the quarter. Coppell Advisory Solutions LLC’s holdings in UnitedHealth Group were worth $521,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Forvis Mazars Wealth Advisors LLC boosted its position in UnitedHealth Group by 2.3% during the first quarter. Forvis Mazars Wealth Advisors LLC now owns 3,320 shares of the healthcare conglomerate’s stock worth $1,739,000 after acquiring an additional 75 shares during the last quarter. LeConte Wealth Management LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $338,000. Finally, George Kaiser Family Foundation boosted its holdings in shares of UnitedHealth Group by 135.5% during the 1st quarter. George Kaiser Family Foundation now owns 1,100 shares of the healthcare conglomerate’s stock worth $576,000 after purchasing an additional 633 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5%

NYSE:UNH opened at $341.83 on Monday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock’s fifty day moving average is $339.84 and its two-hundred day moving average is $317.20. The stock has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.15 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on UNH shares. Barclays boosted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price on the stock. in a report on Wednesday, October 29th. TD Cowen lifted their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Finally, KeyCorp raised their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.